SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-088466
Filing Date
2024-04-05
Accepted
2024-04-05 16:09:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d769374ddefa14a.htm DEFA14A 26332
2 GRAPHIC g769374snap1.jpg GRAPHIC 7241
3 GRAPHIC g769374snap2.jpg GRAPHIC 21713
4 GRAPHIC g769374snap3.jpg GRAPHIC 54659
5 GRAPHIC g769374snap4.jpg GRAPHIC 1014
  Complete submission text file 0001193125-24-088466.txt   144544
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38997 | Film No.: 24826557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)